Increasing brain cell activity to prevent dystonia in children with cerebral palsy
Modulation of striatal cholinergic interneuron activity to prevent dystonic cerebral palsy
This study is looking at whether boosting certain brain cells can help prevent dystonia in kids who had brain injuries at birth, using mice to learn more about how this condition develops and to find new ways to help children before they show any symptoms.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10899773 on NIH RePORTER |
What this research studies
This research investigates whether enhancing the activity of specific brain cells, known as cholinergic interneurons, can prevent the development of dystonia in children who have experienced brain injuries at birth. Using a mouse model that mimics the effects of neonatal brain injury, the study aims to understand the unique mechanisms behind dystonic cerebral palsy and explore potential new treatments. By focusing on the early stages of brain development, the research seeks to identify interventions that could be applied before symptoms appear, potentially leading to better outcomes for affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children who have experienced neonatal brain injuries and are at risk of developing dystonia.
Not a fit: Patients who do not have a history of neonatal brain injury or who are not at risk for dystonia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments for dystonia in children with cerebral palsy, improving their quality of life.
How similar studies have performed: While research on dystonia has been conducted, this specific approach of targeting cholinergic interneuron activity in the context of dystonic cerebral palsy is novel and has not been extensively tested.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Aravamuthan, Bhooma — Washington University
- Study coordinator: Aravamuthan, Bhooma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.